Published online 13 October 2003 doi:10.1084/jem.20030471
© Rockefeller University Press,
0022-1007/2003/10/1189 $5.00
The Journal of Experimental Medicine, Volume 198, Number 8, 1189-1200
Targeted Inactivation of the IL-4 Receptor
Chain I4R Motif Promotes Allergic Airway Inflammation
Frank Blaeser1,
Paul J. Bryce2,
Nga Ho1,
Vidya Raman1,
Fatma Dedeoglu2,
Debra D. Donaldson3,
Raif S. Geha2,
Hans C. Oettgen2 and
Talal A. Chatila1,4
1 Department of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110
2 Department of Pediatrics, Harvard Medical School, Boston, MA 02115
3 Department of Respiratory Disease, Wyeth Research, Cambridge, MA 02140
4 Department of Pathology and Immunology and the Center for Immunology, Washington University School of Medicine, St. Louis, MO 63110
Address correspondence to Talal A. Chatila, Dept. of Pediatrics, The David Geffen School of Medicine, University of California at Los Angeles, 10833 Le Conte Ave., Los Angeles, CA 90095-1752. Phone: (310) 825-4125; Fax: (310) 206-4584; email: Tchatila{at}mednet.ucla.edu
The insulin/interleukin-4 (IL-4) receptor (I4R) motif mediates the association of insulin receptor substrate (IRS)-2 with the interleukin-4 (IL-4)R
chain and transduces mitogenic signals in response to IL-4. Its physiological functions were analyzed in mice with a germline point mutation that changed the motif's effector tyrosine residue into phenylalanine (Y500F). The Y500F mutation abrogated IRS-2 phosphorylation and impaired IL-4induced CD4+ T lymphocyte proliferation but left unperturbed Stat6 activation, up-regulation of IL-4-responsive gene products, and Th cell differentiation under Th2 polarizing conditions. However, in vivo the Y500F mutation was associated with increased allergen-induced IgE production, airway responsiveness, tissue eosinophilia, and mucus production. These results define an important role for the I4R motif in regulating allergic inflammation.
Key Words: interleukin 4 receptor targeted mutagenesis immunoglobulin E insulin receptor substrate asthma

CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
-
Tachdjian, R., Mathias, C., Al Khatib, S., Bryce, P. J., Kim, H. S., Blaeser, F., O'Connor, B. D., Rzymkiewicz, D., Chen, A., Holtzman, M. J., Hershey, G. K., Garn, H., Harb, H., Renz, H., Oettgen, H. C., Chatila, T. A.
(2009). Pathogenicity of a disease-associated human IL-4 receptor allele in experimental asthma. JEM
206: 2191-2204
[Abstract]
[Full Text]
-
Wills-Karp, M., Finkelman, F. D.
(2008). Untangling the Complex Web of IL-4- and IL-13-Mediated Signaling Pathways. Sci Signal
1: pe55-pe55
[Abstract]
[Full Text]
-
Heller, N. M., Qi, X., Junttila, I. S., Shirey, K. A., Vogel, S. N., Paul, W. E., Keegan, A. D.
(2008). Type I IL-4Rs Selectively Activate IRS-2 to Induce Target Gene Expression in Macrophages. Sci Signal
1: ra17-ra17
[Abstract]
[Full Text]
-
Wei, L. H., Yang, Y., Wu, G., Ignarro, L. J.
(2008). IL-4 and IL-13 upregulate ornithine decarboxylase expression by PI3K and MAP kinase pathways in vascular smooth muscle cells. Am. J. Physiol. Cell Physiol.
294: C1198-C1205
[Abstract]
[Full Text]
-
Stephenson, L. M., Park, D.-S., Mora, A. L., Goenka, S., Boothby, M.
(2005). Sequence Motifs in IL-4R{alpha} Mediating Cell-Cycle Progression of Primary Lymphocytes. J. Immunol.
175: 5178-5185
[Abstract]
[Full Text]
-
Lin, D. A., Boyce, J. A.
(2005). IL-4 Regulates MEK Expression Required for Lysophosphatidic Acid-Mediated Chemokine Generation by Human Mast Cells. J. Immunol.
175: 5430-5438
[Abstract]
[Full Text]
-
Zhou, X., Trudeau, J. B., Schoonover, K. J., Lundin, J. I., Barnes, S. M., Cundall, M. J., Wenzel, S. E.
(2005). Interleukin-13 augments transforming growth factor-{beta}1-induced tissue inhibitor of metalloproteinase-1 expression in primary human airway fibroblasts. Am. J. Physiol. Cell Physiol.
288: C435-C442
[Abstract]
[Full Text]